Rosell-Lallemand

Lallemand Health Solutions is a global leader in the probiotic industry, specializing in the research, development, and manufacturing of bacteria and yeast-based formulations for human health. As a vertically integrated CDMO, the company manages the entire value chain from strain selection and fermentation to the production of finished dosage forms such as capsules, tablets, and sachets. Their extensive portfolio is backed by clinical documentation and targets diverse therapeutic areas including gut health, mental wellness (psychobiotics), immunity, and women's health. Founded on the scientific legacy of Institut Rosell, the company operates multiple GMP-certified facilities across Canada and Europe. They are recognized for pioneering the brain-gut axis field with their proprietary probiotic combinations. Lallemand Health Solutions serves a global clientele of pharmaceutical and dietary supplement companies.